INSIGHT (R)XT. Indications for Diagnosis, Arrhythmia and Monitoring of Reveal XT
- Conditions
- Atrial FibrillationCardiac Arrhythmias
- Registration Number
- NCT00680550
- Lead Sponsor
- Medtronic BRC
- Brief Summary
To describe the clinical indications for Reveal XT in diagnosis and continuous monitoring of arrhythmia and to explore the clinical applications and outcome of arrhythmia monitoring on patient care.
- Detailed Description
Improving the diagnosis and management of cardiac rhythm disturbances remains a major challenge for physicians. Limitations of current cardiac arrhythmia monitoring using ECG, holters or event recorders are that these methods are non-continuous and/or automatic arrhythmia detection is often impossible. The Medtronic Reveal XT Insertable Cardiac Monitor is a programmable device which continuously monitors the patient's subcutaneous ECG and provides information regarding arrhythmia episodes, long term trending of AF burden, patient's activity and heart rate variability. The Reveal XT records cardiac information in response to patient activation and automatically detected arrhythmias thereby offering advantages over conventional tools for long-term arrhythmia monitoring with regard to compliance and recording time.
The clinical applications for Reveal XT are varied. Diagnostic, arrhythmia monitoring and arrhythmia management functions can be discriminated.
This study is a prospective, observational, multicenter international post-market study. The results of this study will describe the different patient groups for which the Reveal XT is being used for the diagnosis and monitoring of various cardiac arrhythmias. This study will also collect data regarding the clinical consequences of using the Reveal XT and the influence of Reveal XT data on clinical care pathways. The physician as well as the patient's satisfaction with the device will be evaluated. The study will be conducted in 60-100 centers primarily in Europe. It is expected that 800-1000 patients will be enrolled.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1003
- Patient implanted or scheduled for an implant with a Reveal XT Insertable Cardiac Monitor System for arrhythmia diagnosis or monitoring
- Patient must be willing to sign a Patient Data Release Form (or Informed Consent where applicable)
- Enrollment outside a 30-day window from the planned/performed Reveal XT implant procedure (from 15 days pre-implant until 15 days post implant)
- Patient is implanted with a pacemaker, ICD, CRT-device or an implantable hemodynamic monitoring system
- Unwillingness or inability to cooperate or give written informed consent or, if the patient is a minor and the legal guardian refuses to give consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method descriptive: clinical indications for Reveal XT 2008-2012 To describe the patient population implanted with a Reveal XT for arrhythmia diagnosis and monitoring
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (55)
Republican Scientific Practical Center
🇧🇾Minsk, Belarus
Kardiologicka ambulance
🇨🇿Ostrava, Czech Republic
Ziekenhuis De Tjongerschans
🇳🇱Heerenveen, Netherlands
Medisch Centrum Leeuwarden
🇳🇱Leeuwarden, Netherlands
Centro Hospitalar do Porto - Hospital de Santo Antonio
🇵🇹Porto, Portugal
Arytmologicke oddelenie VUSCH
🇸🇰Kosice, Slovakia
Medizinische Hochshule
🇩🇪Hannover, Germany
Klinik Augustinum
🇩🇪München, Germany
Kardiocentrum
🇩🇪Frankfurt, Germany
Herzzentrum Dresden
🇩🇪Dresden, Germany
Zentralklinik Bad Berka
🇩🇪Bad Berka, Germany
Kardiologische Praxis
🇩🇪Dessau, Germany
Klinikum Coburg
🇩🇪Coburg, Germany
Universitatsklinikum
🇩🇪Freiburg, Germany
Universitaetsklinikum Tuebingen
🇩🇪Tuebingen, Germany
Klinkum Wels-Grieskirchen GmbH
🇦🇹Wels, Austria
Universitätsklinik für Innere Medizin
🇦🇹Wien, Austria
Fakultni nemocnice Brno
🇨🇿Brno, Czech Republic
Asklepios Klinik
🇩🇪Hamburg-Harburg, Germany
Krankenhaus der Elisabethinen
🇦🇹Linz, Austria
Tampere University Hospital
🇫🇮Tampere, Finland
Fakultni nemocnice u sv. Anny v Brne
🇨🇿Brno, Czech Republic
Klinikum der Universität München-Großhadern (LMU)
🇩🇪München, Germany
Hopital Cantonal Universitaires de Geneve
🇨ðŸ‡Geneve, Switzerland
Liverpool Heart and Chest Hospital
🇬🇧Liverpool, United Kingdom
St.-Marien-Hospital
🇩🇪Bonn-Venusberg, Germany
St. Johannes Hospital
🇩🇪Hagen, Germany
Universitares Herzzentrum
🇩🇪Hamburg, Germany
Klinikum Nürnberg Süd
🇩🇪Nürnberg, Germany
Herzzentrum, University of Leipzig
🇩🇪Leipzig, Germany
St. Martinus Hospital
🇩🇪Olpe, Germany
DRK-Krankenhaus Mölln-Ratzeburg
🇩🇪Ratzeburg, Germany
Krankenhaus Barmherzige Brueder
🇩🇪Regensburg, Germany
Krankenhaus Reinbek, St.-Adolf-Stift
🇩🇪Reinbek, Germany
Azienda Ospedaliera Universitaria Careggi
🇮🇹Florence, Italy
Gelre Apeldoorn
🇳🇱Apeldoorn, Netherlands
Bethesda Ziekenhuis
🇳🇱Hoogeveen, Netherlands
Westfries Gasthuis
🇳🇱Hoorn, Netherlands
Vlietland Ziekenhuis
🇳🇱Schiedam, Netherlands
Diakonessenhuis Utrecht
🇳🇱Utrecht, Netherlands
Maasland Ziekenhuis
🇳🇱Sittard, Netherlands
Tyumen Cardiology Centre
🇷🇺Tyumen, Russian Federation
Almazov Federeal Heart, Blood and Endocrinology Centre
🇷🇺St. Petersburg, Russian Federation
Scientific Research Center of Cardio Vascular Surgery by A.N. Bakulev
🇷🇺Moscow, Russian Federation
State Research Institute of Circulation Pathology
🇷🇺Novosibirsk, Russian Federation
University Hospital Örebro
🇸🇪Örebro, Sweden
University Medical Center Ljubljana
🇸🇮Ljubljana, Slovenia
Complejo Hospitalario Universitario de Vigo
🇪🇸Vigo, Spain
Hopital Cantonal de Fribourg
🇨ðŸ‡Fribourg, Switzerland
Hopital de Pourtales de Neuchatel
🇨ðŸ‡Neuchatel, Switzerland
Hopital de Sion CHCVS
🇨ðŸ‡Sion, Switzerland
Sheikh Khalifa Medical Center
🇦🇪Abu Dhabi, United Arab Emirates
UniversitatsSpital
🇨ðŸ‡Zurich, Switzerland
Uniklinik Homburg - Klinik fur Innere Medizin III
🇩🇪Homburg, Germany
Universitätsklinikum Münster
🇩🇪Münster, Germany